Discontinuation report ARZERRA
Report ID | 78215 |
Drug Identification Number | 02381559 |
Brand name | ARZERRA |
Common or Proper name | ARZERRA 100MG VIALS 5ML X 3 |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | Ofatumumab |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5ml x3 |
ATC code | L01XC |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-03-11 |
Actual discontinuation date | 2019-03-11 |
Remaining supply date | 2019-03-11 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-03-11 | English | Compare |
v2 | 2019-03-11 | English | Compare |
v3 | 2019-03-11 | French | Compare |
v4 | 2019-03-12 | English | Compare |
Showing 1 to 4 of 4